|
|
|
Atrial Fibrillation Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Atrial Fibrillation.
Please click "Search" to find Atrial Fibrillation clinical trials and medical research studies or read below for information on Atrial Fibrillation diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 4 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias - NCT00747838-23298
Conditions: Atrial Fibrillation
Location: Richmond, VA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-02114
Conditions: Atrial Fibrillation
Location: Boston, MA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-02115
Conditions: Atrial Fibrillation
Location: Boston, MA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-02905
Conditions: Atrial Fibrillation
Location: Providence, RI
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-05401
Conditions: Atrial Fibrillation
Location: Burlington, VT
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-06102
Conditions: Atrial Fibrillation
Location: Hartford, CT
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-10467
Conditions: Atrial Fibrillation
Location: Bronx, NY
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-19096
Conditions: Atrial Fibrillation
Location: Wynnewood, PA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-19107
Conditions: Atrial Fibrillation
Location: Philadelphia, PA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-20010
Conditions: Atrial Fibrillation
Location: Washington, DC
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-22908
Conditions: Atrial Fibrillation
Location: Charlottesville, VA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-23249
Conditions: Atrial Fibrillation
Location: Richmond, VA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-24501
Conditions: Atrial Fibrillation
Location: Lynchburg, VA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-27704
Conditions: Atrial Fibrillation
Location: Durham, NC
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-29425
Conditions: Atrial Fibrillation
Location: Charleston, SC
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-32114
Conditions: Atrial Fibrillation
Location: Daytona Beach, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-32174
Conditions: Atrial Fibrillation
Location: Ormond Beach, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-32610
Conditions: Atrial Fibrillation
Location: Gainesville, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-32803
Conditions: Atrial Fibrillation
Location: Orlando, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-33606
Conditions: Atrial Fibrillation
Location: Tampa, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-33756
Conditions: Atrial Fibrillation
Location: Clearwater, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-33805
Conditions: Atrial Fibrillation
Location: Lakeland, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-34695
Conditions: Atrial Fibrillation
Location: Safety Harbor, FL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-35801
Conditions: Atrial Fibrillation
Location: Huntsville, AL
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-37075
Conditions: Atrial Fibrillation
Location: Hendersonville, TN
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-37172
Conditions: Atrial Fibrillation
Location: Springfield, TN
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-43608
Conditions: Atrial Fibrillation
Location: Toledo, OH
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-44304
Conditions: Atrial Fibrillation
Location: Akron, OH
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-45219
Conditions: Atrial Fibrillation
Location: Cincinnati, OH
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-46230
Conditions: Atrial Fibrillation
Location: Hammond, IN
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-46321
Conditions: Atrial Fibrillation
Location: Munster, IN
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-48201
Conditions: Atrial Fibrillation
Location: Detriot, MI
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-48910
Conditions: Atrial Fibrillation
Location: Lansing, MI
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-49770
Conditions: Atrial Fibrillation
Location: Petoskey, MI
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-52803
Conditions: Atrial Fibrillation
Location: Davenport, IA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-55455
Conditions: Atrial Fibrillation
Location: Minneapolis, MN
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-59901
Conditions: Atrial Fibrillation
Location: Kalispell, MT
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-63110
Conditions: Atrial Fibrillation
Location: St. Louis, MO
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-63703
Conditions: Atrial Fibrillation
Location: Cape Girardeau, MO
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-78539
Conditions: Atrial Fibrillation
Location: Edinburg, TX
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-80045
Conditions: Atrial Fibrillation
Location: Aurora, CO
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-83712
Conditions: Atrial Fibrillation
Location: Boise, ID
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-84157
Conditions: Atrial Fibrillation
Location: Murray, UT
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-94143
Conditions: Atrial Fibrillation
Location: San Francisco, CA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-94705
Conditions: Atrial Fibrillation
Location: Berkley, CA
- A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF) - NCT00989001-95817
Conditions: Atrial Fibrillation
Location: Sacramento, CA
- ABLATE Continued Access Trial - NCT01174745-
Conditions: Atrial Fibrillation
Location: Cleveland, OH
- ABLATE Continued Access Trial - NCT01174745-23507
Conditions: Atrial Fibrillation
Location: Norfolk, VA
- ABLATE Continued Access Trial - NCT01174745-46290
Conditions: Atrial Fibrillation
Location: Indianapolis, IN
- ABLATE Continued Access Trial - NCT01174745-48910
Conditions: Atrial Fibrillation
Location: Lansing, MI
- ABLATE Continued Access Trial - NCT01174745-49503
Conditions: Atrial Fibrillation
Location: Grand Rapids, MI
- ABLATE Continued Access Trial - NCT01174745-49684
Conditions: Atrial Fibrillation
Location: Traverse City, MI
- Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes - NCT01173796-
Conditions: Atrial Fibrillation - Perimitral Flutter
Location: Austin, TX
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-02114
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Boston, MA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-02115
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Boston, MA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-06115
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Hartford, CT
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-07601
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Hackensack, NJ
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-08103
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Camden, NJ
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-08901
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: News Brunswick, NJ
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-10016
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: New York, NY
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-10025
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: New York, NY
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-10029
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: New York, NY
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-10032
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: New York, NY
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-12205
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Albany, NY
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-15213
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Pittsburgh, PA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-17033
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Hershey, PA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-19096
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Wynnewood, PA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-19102
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Philadelphia, PA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-19104
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Philadelphia, PA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-19107
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Philadelphia, PA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-20037
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Washington, D.C., DC
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-20307
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Washington, D.C., DC
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-21287
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Baltimore, MD
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-22031
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Fairfax, VA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-22908
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Charlottesville, VA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-23219
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Richmond, VA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-23507
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Norfolk, VA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-27157
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Winston-Salem, NC
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-27599
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Chapel Hill, NC
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-27705
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Durham, NC
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-28203
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Charlotte, NC
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-32803
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Orlando, FL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-33606
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Tampa, FL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-35294
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Birmingham, AL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-37232
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Nashville, TN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-37404
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Chattanooga, TN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-43210
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Columbus, OH
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-43614
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Toledo, OH
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-44106
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Cleveland, OH
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-44193
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Cleveland, OH
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-46202
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Indianapolis, IN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-46260
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Indianapolis, IN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-48109
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Ann Arbor, MI
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-48197
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Ypsilanti, MI
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-50226
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: West Des Moines, IA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-53215
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Milwaukee, WI
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-54449
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Marshfield, WI
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-55102
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: St. Paul, MN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-55426
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: St. Louis Park, MN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-55455
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Minneapolis, MN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-55905
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Rochester, MN
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-59802
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Missoula, MT
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-60010
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Barrington, IL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-60153
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Maywood, IL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-60201
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Evanston, IL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-60611
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Chicago, IL
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-63131
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: St. Louis, MO
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-68506
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Lincoln, NE
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-72205
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Little Rock, AR
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-75093
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Plano, TX
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-75226
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Dallas, TX
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-77030
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Houston, TX
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-78705
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Austin, TX
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-80012
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Aurora, CO
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-80907
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Colorado Springs, CO
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-84143
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Salt Lake City, UT
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-84403
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Ogden, UT
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-84604
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Provo, UT
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-85006
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Phoenix, AZ
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-85014
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Phoenix, AZ
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-90017
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Los Angeles, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-90027
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Los Angeles, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-90033
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Los Angeles, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-90048
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Los Angeles, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-92103
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: San Diego, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-92123
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: San Diego, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-94062
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Redwood City, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-94143
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: San Francisco, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-94305
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Stanford, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-95817
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Sacramento, CA
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-97201
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Portland, OR
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-97225
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Portland, OR
- Ablation Versus Anti-Arrhythmic (AA) Drug Therapy for AF - Pivotal Trial - NCT00911508-98195
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Seattle, WA
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-17405
Conditions: Atrial Fibrillation
Location: York, PA
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-19104
Conditions: Atrial Fibrillation
Location: Philadelphia, PA
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-40506
Conditions: Atrial Fibrillation
Location: Lexington, KY
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-52242
Conditions: Atrial Fibrillation
Location: Iowa City, IA
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-80045
Conditions: Atrial Fibrillation
Location: Aurora, CO
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-80120
Conditions: Atrial Fibrillation
Location: Littleton, CO
- AMPLATZER Cardiac Plug Clinical Trial - NCT01118299-90017
Conditions: Atrial Fibrillation
Location: Los Angeles, CA
- Assessing Arrhythmias After Ablation Using Implantable Recorders - NCT01176617-19014
Conditions: Atrial Fibrillation
Location: Philadelphia, PA
- Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation - NCT00818012-68131
Conditions: Atrial Fibrillation
Location: Omaha, NE
- Atrial Fibrillation Ablation Device Comparison Study - NCT00466973-11219
Conditions: Atrial Fibrillation
Location: Brooklyn, NY
- Atrial Fibrillation Recurrence in Sleep Apnea - NCT00263757-55905
Conditions: Sleep Apnea - Atrial Fibrillation
Location: Rochester, MN
- Atrial Fibrillation/Flutter Outcome Risk Determination - NCT01138644-37232
Conditions: Atrial Fibrillation - Atrial Flutter
Location: Nashville, TN
- AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB - NCT00571779-21218
Conditions: Atrial Fibrillation
Location: Baltimore, MD
- AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB - NCT00571779-23298
Conditions: Atrial Fibrillation
Location: Richmond, VA
- AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB - NCT00571779-32610
Conditions: Atrial Fibrillation
Location: Gainesville, FL
- AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB - NCT00571779-43213
Conditions: Atrial Fibrillation
Location: Columbus, OH
- AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB - NCT00571779-75093
Conditions: Atrial Fibrillation
Location: Plano, TX
- AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study - NCT00589303-37404
Conditions: Atrial Fibrillation - Heart Failure
Location: Chattanooga, TN
- AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study - NCT00589303-47710
Conditions: Atrial Fibrillation - Heart Failure
Location: Evansville, IN
- AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study - NCT00589303-55905
Conditions: Atrial Fibrillation - Heart Failure
Location: Rochester, MN
- AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study - NCT00589303-85259
Conditions: Atrial Fibrillation - Heart Failure
Location: Scottsdale, AZ
- AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study - NCT00589303-97239
Conditions: Atrial Fibrillation - Heart Failure
Location: Portland, OR
- Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation - NCT00765089-15102
Conditions: Postoperative Atrial Fibrillation
Location: Pittsburgh, PA
- Catheter Ablation for Atrial Fibrillation and Heart Failure - NCT01082601-07450
Conditions: Congestive Heart Failure - Atrial Fibrillation - Arrhythmia
Location: Ridgewood, NJ
- Catheter Ablation for Atrial Fibrillation and Heart Failure - NCT01082601-10025
Conditions: Congestive Heart Failure - Atrial Fibrillation - Arrhythmia
Location: New York, NY
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-04143
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: San Francisco, CA
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-10029
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: New York, NY
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-19104
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Philadelphia, PA
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-21201
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Baltimore, MD
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-32610
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Gainesville, FL
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-37232
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Nashville, TN
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-48202
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Detroit, MI
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-54449
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Marshfield, WI
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-55905
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Rochester, MN
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-63110
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: St. Louis, MO
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-77555
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Galveston, TX
- Clarification of Optimal Anticoagulation Through Genetics - NCT00839657-84157
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Murray, UT
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-10029
Conditions: Paroxysmal Atrial Fibrillation
Location: New York, NY
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-19104
Conditions: Paroxysmal Atrial Fibrillation
Location: Philadelphia, PA
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-22908
Conditions: Paroxysmal Atrial Fibrillation
Location: Charlottesville, VA
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-23507
Conditions: Paroxysmal Atrial Fibrillation
Location: Norfolk, VA
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-29425
Conditions: Paroxysmal Atrial Fibrillation
Location: Charleston, SC
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-35294
Conditions: Paroxysmal Atrial Fibrillation
Location: Birmingham, AL
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-48072
Conditions: Paroxysmal Atrial Fibrillation
Location: Royal Oak, MI
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-77030
Conditions: Paroxysmal Atrial Fibrillation
Location: Houston, TX
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-78705
Conditions: Paroxysmal Atrial Fibrillation
Location: Austin, TX
- Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation - NCT00971204-90404
Conditions: Paroxysmal Atrial Fibrillation
Location: Santa Monica, CA
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-07631
Conditions: Atrial Fibrillation
Location: Englewood, NJ
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-10075
Conditions: Atrial Fibrillation
Location: New York, NY
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-19104
Conditions: Atrial Fibrillation
Location: Philadelphia, PA
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-22042
Conditions: Atrial Fibrillation
Location: Falls Church, VA
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-33701
Conditions: Atrial Fibrillation
Location: St. Petersburg, FL
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-44195
Conditions: Atrial Fibrillation
Location: Cleveland, OH
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-53515
Conditions: Atrial Fibrillation
Location: Milwaukee, WI
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-55902
Conditions: Atrial Fibrillation
Location: Rochester, MN
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-60611
Conditions: Atrial Fibrillation
Location: Chicago, IL
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-63110
Conditions: Atrial Fibrillation
Location: St. Louis, MO
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-85260
Conditions: Atrial Fibrillation
Location: Phoenix, AZ
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-87102
Conditions: Atrial Fibrillation
Location: Albuquerque, NM
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-90033
Conditions: Atrial Fibrillation
Location: Los Angeles, CA
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-92270
Conditions: Atrial Fibrillation
Location: Palm Springs, CA
- Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study - NCT00431834-94520
Conditions: Atrial Fibrillation
Location: Concord, CA
- Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study - NCT00756886-35294
Conditions: Arrhythmia
Location: Birmingham, AL
- Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation - NCT00584922-73104
Conditions: Atrial Fibrillation
Location: Oklahoma City, OK
- Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation - NCT01173809-78705
Conditions: Atrial Fibrillation
Location: Austin, TX
- Effect of Balloon Cryoablation on Left Atrial Function - NCT00821015-33136
Conditions: Atrial Fibrillation
Location: Miami, FL
- Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) - NCT00786474-27715
Conditions: Arterial Thromboembolic Events - Atrial Fibrillation
Location: Durham, NC
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-12401
Conditions: Atrial Fibrillation
Location: Kingston, NY
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-14215
Conditions: Atrial Fibrillation
Location: Buffalo, NY
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-17011
Conditions: Atrial Fibrillation
Location: Camp Hill, PA
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-33707
Conditions: Atrial Fibrillation
Location: St. Petersburg, FL
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-33952
Conditions: Atrial Fibrillation
Location: Port Charlotte, FL
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-35235
Conditions: Atrial Fibrillation
Location: Birmingham, AL
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-36608
Conditions: Atrial Fibrillation
Location: Mobile, AL
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-53715
Conditions: Atrial Fibrillation
Location: Madison, WI
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-63122
Conditions: Atrial Fibrillation
Location: St. Louis, MO
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-90048
Conditions: Atrial Fibrillation
Location: Los Angeles, CA
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers - NCT01135017-92501
Conditions: Atrial Fibrillation
Location: Riverside, CA
- Effects of Fish Oil on Post Ablation Arrhythmias - NCT00791089-48109
Conditions: Atrial Fibrillation
Location: Ann Arbor, MI
- Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation - NCT00951301-55902A
Conditions: Atrial Fibrillation
Location: Rochester, MN
- Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation - NCT00951301-55902B
Conditions: Atrial Fibrillation
Location: Rochester, MN
- Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation - NCT00552084-37232
Conditions: Atrial Fibrillation
Location: Nashville, TN
- Gene Expression Profiling in Subjects With Postoperative Atrial Fibrillation After Cardiac Surgery - NCT00833313-02115
Conditions: Atrial Fibrillation
Location: Boston, MA
- Genomics and Postoperative Atrial Fibrillation - NCT00280163-15213
Conditions: Postoperative Atrial Fibrillation, Genomics
Location: Pittsburgh, PA
- Genotype-Guided Warfarin Therapy Trial - NCT00904293-27599
Conditions: Atrial Fibrillation - Deep Vein Thrombosis - Pulmonary Embolism - Artificial Heart Valve
Location: Chapel Hill, NC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Menomonee Falls, WI
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-16602
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Altoona, PA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-19522
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Fleetwood, PA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-23294
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Richmond, VA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-23502
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Norfolk, VA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-27408
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Greensboro, NC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-28207
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Charlotte, NC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-28557
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Morehead City, NC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-28655
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Morganton, NC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-29302
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Spartanburg, SC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-29651
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Greer, SC
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-30013
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Conyers, GA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-30039
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Snellville, GA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-30188
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Woodstock, GA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-32114
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Daytona, FL
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-33173
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Miami, FL
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-33484
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Delray Beach, FL
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-34748
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Leesburg, FL
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-45505
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Springfield, OH
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-68025
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Fremont, NE
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-71291
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: West Monroe, LA
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-80904
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Colorado Springs, CO
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-82220
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Belleville, IL
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-84120
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: West Valley City, UT
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-85283
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Tempe, AZ
- Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation - NCT00781391-85635
Conditions: Stroke - Atrial Fibrillation - Embolism
Location: Sierra Vista, AZ
- Ibutilide Administration During Pulmonary Vein Ablation - NCT00589992-47303
Conditions: Atrial Fibrillation - Pulmonary Vein Ablation
Location: Muncie, IN
- Implantable Loop Recorders in Post-atrial Fibrillation (AF) Ablation: RPAF-A - NCT01061125-44193
Conditions: Atrial Fibrillation
Location: Cleveland, OH
- Implanted Loop Recorder Post Atrial Fibrillation Ablation - NCT00915720-48910
Conditions: Atrial Fibrillation
Location: Lansing, MI
- Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making - NCT00829478-06516
Conditions: Atrial Fibrillation
Location: West Haven, CT
- Intra-Cardiac Echocardiography Guided Cardioversion to Help Interventional Procedures (ICE-CHIP) Study - NCT00281073-32224
Conditions: Atrial Fibrillation
Location: Jacksonville, FL
- Intra-Cardiac Echocardiography Guided Cardioversion to Help Interventional Procedures (ICE-CHIP) Study - NCT00281073-44195
Conditions: Atrial Fibrillation
Location: Cleveland, OH
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|